Quantcast
Last updated on April 23, 2014 at 11:31 EDT

Latest Urodynamic testing Stories

2014-02-04 23:27:15

DiaperBuys, a national online retailer of incontinence supplies, wants to ensure women everywhere are aware of the symptoms, risks and tips to manage a common health issue: urinary tract infections (UTIs) or bladder infections in women, and in particular, in older women. Wixom, MI (PRWEB) February 04, 2014 DiaperBuys, a national online retailer of incontinence supplies, wants to ensure women everywhere are aware of the symptoms, risks and tips to manage a common health issue: urinary...

2014-01-15 10:30:44

Virtual reality, dance and fun are not the first things that come to mind when we think of treating urinary incontinence in senior women. However, these concepts were the foundations of a promising study by Dr. Chantal Dumoulin, PhD, Canada Research Chair in Urogynaecological Health and Aging, a researcher at the Institut universitaire de gériatrie de Montréal, and an associate professor in the Physiotherapy Program of the Rehabilitation School at Université de Montréal, and her master's...

2013-04-10 08:31:06

Myrbetriq is now available in pharmacies across Canada MARKHAM, ON, April 10, 2013 /CNW/ - Overactive bladder (OAB) is a chronic, debilitating condition that can have a profound, negative impact on a patient's quality of life.( 1) Many patients with OAB are plagued by depression,(2) experience a disruption in sleep,(3) limit their social activity,(4) and experience a loss of control and decreased self-esteem.(5) An estimated 2.9 million Canadian men and women(6) suffer from OAB...

2013-03-08 08:23:03

MARKHAM, ON, March 8, 2013 /CNW/ - Astellas Pharma Canada, Inc., the Canadian subsidiary of Tokyo-based Astellas Pharma Inc., announced today Health Canada's approval of Myrbetriq(TM) (mirabegron, extended-release tablets). Mirabegron is indicated for the treatment of overactive bladder (OAB) with symptoms of urgency, urgency incontinence and urinary frequency.(1 )Mirabegron, a selective b3-adrenoceptor agonist, is a "first in class" therapeutic agent with a mechanism of action...

2013-02-25 16:26:39

MINNEAPOLIS, Feb. 25, 2013 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ:UPI), a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, today announced there will be several presentations on the office-based Urgent PC Neuromodulation System at professional society meetings in February and March 2013. Society for Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU), February 27 -March 2, 2013 in...

2013-01-23 23:04:16

Women suffering with bladder control issues are already inconvenienced by the very nature of their problem. For this reason, Women´s Excellence in Bladder Control has decided to provide all testing for urinary incontinence in the comfort and convenience of the office setting. Goodrich, MI (PRWEB) January 23, 2013 Most women today are taking charge of their own health and are becoming savvy consumers of healthcare services. No longer do women accept what is offered as the status quo....

2012-11-27 08:27:29

MINNEAPOLIS, Nov. 27, 2012 /PRNewswire/ -- Uroplasty, Inc. (NASDAQ: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today announced significant new coverage decisions by private payers and Medicare. Effective October 2012, Health Net(®), one of the largest private insurance payers in California, began covering posterior tibial nerve stimulation (PTNS) for the treatment of overactive bladder...

2012-10-22 07:29:08

NORTHBROOK, Ill., Oct. 22, 2012 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that MYRBETRIQ(TM) (mirabegron) extended-release tablets, indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and urinary frequency, is now available through U.S. pharmacies. "The availability of MYRBETRIQ marks an important milestone in our ongoing...

2012-05-03 09:15:25

NIH-funded study finds pre-operative office visit alone sufficient for comparable outcomes An invasive and costly test commonly done in women before surgery for stress urinary incontinence may not be necessary, according to a study funded by the National Institutes of Health. The study compared results after both a pre-operative check-up in a doctor's office and bladder function tests to results after only the office check-up. Women who had only the office check-up had equally successful...

2010-04-19 07:30:00

NATICK, Mass., April 19 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that it has entered into a four-year exclusive marketing agreement with Bladder Health Network (BHN), a privately held company offering advanced testing solutions for urinary incontinence. BHN offers an integrated diagnostic solutions platform that combines software, staffing, equipment, supplies and results analysis, providing physicians and their patients with greater access to...